Gary Mccord

Gary McCord holds over 30 years of sales, management, and leadership experience with numerous early-stage companies such as TriReme Medical, Sapheon, Cardiovascular Systems, Inc., Fox Hollow Technologies, Interventional Technologies, Inc., Ventritex, Heart Technologies, and Pilot Cardiovascular Systems. All of these early-stage companies positively exited with such companies as Bard, Boston Scientific, St Jude Medical, Guidant, Covidien, Medtronic, and Teleflex. Currently, Gary is Executive Vice President of Global Sales and Marketing at Venclose, Inc., a privately held early-stage venous closure company based in San Jose, California. Gary started his career at Schneider Cardiovascular, a division of Pfizer, and holds a Bachelor of Arts in Communications degree from the University of Missouri, Columbia.